JP2012507026A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012507026A5 JP2012507026A5 JP2011533750A JP2011533750A JP2012507026A5 JP 2012507026 A5 JP2012507026 A5 JP 2012507026A5 JP 2011533750 A JP2011533750 A JP 2011533750A JP 2011533750 A JP2011533750 A JP 2011533750A JP 2012507026 A5 JP2012507026 A5 JP 2012507026A5
- Authority
- JP
- Japan
- Prior art keywords
- vegfb
- thbs1
- pgf
- patient
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10964908P | 2008-10-30 | 2008-10-30 | |
| US61/109,649 | 2008-10-30 | ||
| PCT/EP2009/064410 WO2010049538A1 (en) | 2008-10-30 | 2009-10-30 | Biomarkers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012507026A JP2012507026A (ja) | 2012-03-22 |
| JP2012507026A5 true JP2012507026A5 (enExample) | 2012-12-13 |
| JP5749171B2 JP5749171B2 (ja) | 2015-07-15 |
Family
ID=41528764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011533750A Expired - Fee Related JP5749171B2 (ja) | 2008-10-30 | 2009-10-30 | バイオマーカー |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20110294683A1 (enExample) |
| EP (1) | EP2362942B1 (enExample) |
| JP (1) | JP5749171B2 (enExample) |
| CN (1) | CN102203606A (enExample) |
| BR (1) | BRPI0920069A8 (enExample) |
| CA (1) | CA2741117A1 (enExample) |
| ES (1) | ES2640900T3 (enExample) |
| RU (1) | RU2545757C2 (enExample) |
| WO (1) | WO2010049538A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5905003B2 (ja) | 2010-07-09 | 2016-04-20 | ソマロジック・インコーポレーテッド | 肺癌バイオマーカーとその使用 |
| MX350533B (es) | 2010-08-13 | 2017-09-08 | Somalogic Inc | Biomarcadores de cancer pancreatico y usos de los mismos. |
| EP2592423A1 (en) | 2011-11-08 | 2013-05-15 | Zora Biosciences OY | Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment |
| EP2592422A1 (en) | 2011-11-08 | 2013-05-15 | Zora Biosciences OY | Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment |
| JP2014207883A (ja) * | 2013-03-27 | 2014-11-06 | 国立大学法人岡山大学 | がん幹細胞及びその用途 |
| EP3511014A1 (en) * | 2013-05-31 | 2019-07-17 | CoBioRes NV | Human plgf-2 for the prevention or treatment of heart failure resulting from chronic myocardial ischemia |
| EP2843414B1 (en) | 2013-08-26 | 2018-09-19 | Roche Diagniostics GmbH | Marker for statin treatment stratification in heart failure |
| CN103487586B (zh) * | 2013-09-04 | 2015-07-15 | 石家庄洹众生物科技有限公司 | 一种定量检测可溶性生长刺激表达蛋白2的试验装置 |
| PL228091B1 (pl) * | 2014-02-12 | 2018-02-28 | Inst Biochemii I Biofizyki Polskiej Akademii Nauk | Zestaw biomarkerów transkryptomicznych do zastosowania w stratyfikacji indywidualnego ryzyka rozwoju pozawałowej niewydolnosci serca, sposób diagnozowania ryzyka wystapienia u pacjenta pozawałowej niewydolnosci serca i zastosowanie biomarkerów do diagnostyki in vitro |
| US10041120B2 (en) | 2014-05-28 | 2018-08-07 | Scripps Health | Predictive analysis for myocardial infarction |
| CN105243294B (zh) * | 2015-09-18 | 2017-06-09 | 淮南师范学院 | 一种用于预测癌症病人预后相关的蛋白质对的方法 |
| RU2634375C2 (ru) * | 2016-04-18 | 2017-10-26 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт кардиологии" | Способ предупреждения постинфарктного ремоделирования сердца в эксперименте |
| ES2967443T3 (es) * | 2016-07-06 | 2024-04-30 | Guardant Health Inc | Procedimientos de perfilado de fragmentoma de ácidos nucleicos sin células |
| DE102017116204B4 (de) * | 2017-07-18 | 2024-06-27 | Universität Rostock | Verfahren zur Vorhersage der Antwort auf die kardiovaskuläre Regeneration |
| US11708600B2 (en) * | 2017-10-05 | 2023-07-25 | Decode Health, Inc. | Long non-coding RNA gene expression signatures in disease diagnosis |
| CN114449944A (zh) * | 2019-09-30 | 2022-05-06 | 豪夫迈·罗氏有限公司 | 疾病状态预测 |
| JP7489059B2 (ja) * | 2020-04-21 | 2024-05-23 | 国立大学法人横浜国立大学 | 画像生成装置、表示装置、画像生成方法、提示方法およびプログラム |
| US11915807B1 (en) * | 2022-10-11 | 2024-02-27 | Flatiron Health, Inc. | Machine learning extraction of clinical variable values for subjects from clinical record data |
| US11854675B1 (en) | 2022-10-11 | 2023-12-26 | Flatiron Health, Inc. | Machine learning extraction of clinical variable values for subjects from clinical record data |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000052462A1 (en) * | 1999-03-03 | 2000-09-08 | Ludwig Institute For Cancer Research | Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities |
| CN1139811C (zh) * | 1999-11-09 | 2004-02-25 | 赵永同 | 肿瘤早期检测评估试剂盒及其制备工艺 |
| CN1260492A (zh) * | 1999-11-09 | 2000-07-19 | 赵永同 | 肿瘤预后评估试剂盒及其制备工艺 |
| CN100399030C (zh) * | 1999-11-16 | 2008-07-02 | 杰南技术公司 | 用于vegf的elisa |
| CA2409948A1 (en) * | 2000-05-17 | 2001-11-22 | Xuri Li | Methods for detecting for the presence of tumor cells and for screening for anti-tumor agents |
| NZ529915A (en) * | 2001-06-20 | 2007-07-27 | Ludwig Inst Cancer Res | Stimulation of vascularization of ischemic tissue by angiogenesis with VEGF-B186 |
| AU2002356033A1 (en) * | 2001-08-13 | 2003-03-03 | Genetics Development Corporation | A molecular diagnostic and computerized decision support system for selecting the optimum treatment for human cancer |
| US20030096248A1 (en) * | 2001-09-04 | 2003-05-22 | Vitivity, Inc. | Diagnosis and treatment of vascular disease |
| US7435419B2 (en) * | 2002-07-19 | 2008-10-14 | Beth Israel Deaconess Medical Center | Methods of diagnosing and treating pre-eclampsia or eclampsia |
| CA2509063C (en) * | 2002-11-16 | 2010-11-02 | Dade Behring Marburg Gmbh | Scd40l and placental growth factor (plgf) as biochemical marker combinations in cardiovascular diseases |
| WO2005054860A1 (en) * | 2003-12-01 | 2005-06-16 | Dako Denmark A/S | Methods and compositions for immuno-histochemical detection |
| WO2006001888A2 (en) * | 2004-04-16 | 2006-01-05 | Acuity Pharmaceuticals Inc | Compositions and methods for inhibiting angiogenesis |
| US20070037232A1 (en) * | 2005-03-31 | 2007-02-15 | Barasch Jonathan M | Detection of NGAL in chronic renal disease |
| TW200732347A (en) * | 2005-10-06 | 2007-09-01 | Trophogen Inc | VEGF analogs and methods of use |
-
2009
- 2009-10-30 CN CN200980143296XA patent/CN102203606A/zh active Pending
- 2009-10-30 US US12/998,543 patent/US20110294683A1/en not_active Abandoned
- 2009-10-30 EP EP09752320.3A patent/EP2362942B1/en not_active Not-in-force
- 2009-10-30 ES ES09752320.3T patent/ES2640900T3/es active Active
- 2009-10-30 BR BRPI0920069A patent/BRPI0920069A8/pt not_active IP Right Cessation
- 2009-10-30 WO PCT/EP2009/064410 patent/WO2010049538A1/en not_active Ceased
- 2009-10-30 RU RU2011121613/15A patent/RU2545757C2/ru active
- 2009-10-30 CA CA2741117A patent/CA2741117A1/en not_active Abandoned
- 2009-10-30 JP JP2011533750A patent/JP5749171B2/ja not_active Expired - Fee Related
-
2015
- 2015-09-22 US US14/861,506 patent/US20160188835A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2011121613A (ru) | Биомаркеры | |
| US20120219943A1 (en) | Methods of prognosis and diagnosis in chronic heart failure | |
| CN104144943B (zh) | 评估肾结构改变和结果 | |
| JP2025029196A (ja) | 心臓血管疾患及び事象のための診断及び予後方法 | |
| CA3052349C (en) | Proadm as marker indicating an adverse event | |
| US11041864B2 (en) | Method for prediction of prognosis of sepsis | |
| US20140045714A1 (en) | Novel Biomarkers For Cardiovascular Injury | |
| Kiernan et al. | Multiplexed mass spectrometric immunoassay in biomarker research: a novel approach to the determination of a myocardial infarct | |
| US20120295797A1 (en) | Methods for diagnosis and prognosis of pulmonary hypertension | |
| JP6416778B2 (ja) | 急性腎臓損傷 | |
| RU2764766C2 (ru) | Гистоны и/или proadm в качестве маркеров, свидетельствующих об органной дисфункции | |
| US20130210667A1 (en) | Biomarkers for Predicting Kidney and Glomerular Pathologies | |
| EP3497451A1 (en) | Histones and/or proadm as markers indicating an adverse event | |
| EP2729181A1 (en) | Methods and compositions for assigning likelihood of acute kidney injury progression | |
| Argan et al. | Associations between neutrophil gelatinase associated lipocalin, neutrophil-to-lymphocyte ratio, atrial fibrillation and renal dysfunction in chronic heart failure | |
| WO2015164616A1 (en) | Biomarkers for detection of tuberculosis | |
| Baroni et al. | A false positive case of high-sensitivity cardiac troponin in a patient with acute chest pain: Analytical study of the interference | |
| WO2014061456A1 (ja) | 統合失調症マーカーセット及びその利用 | |
| JP2024540836A5 (enExample) | ||
| US20150105291A1 (en) | Method, kit, and apparatus for evaluating ischemic heart disease | |
| WO2021024856A1 (ja) | 間質性肺炎のタンパク質診断バイオマーカー | |
| WO2020216904A1 (en) | Diagnosis markers for atrial fibrillation | |
| CN120539404B (zh) | 一种辅助诊断系统性红斑狼疮的生物标志物及其应用 | |
| US8962257B2 (en) | Methods for diagnosing heart failure and other cardiac diseases | |
| CN121656576A (zh) | 生物标志物在制备预测反复流产风险的产品中的应用 |